Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Kura Oncology, Inc.”

21 pharma patents match "Kura Oncology, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 21
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 21 pharmaceutical patents matching "Kura Oncology, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

21 results for “Kura Oncology, Inc.” · 30,257 patents in full index Clear search

  1. US 12410184

    Crystalline forms of a menin inhibitor

    Kura Oncology, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted

  2. US 12018011

    Macrocyclic compounds and compositions, and methods of preparing and using the same

    Kura Oncology, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted

  3. US 11944627

    Methods for treating hematological malignancies and Ewing's sarcoma

    Kura Oncology, Inc. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted

  4. US 11672774

    Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

  5. US 11649251

    Substituted inhibitors of menin-MLL and methods of use

    Kura Oncology, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  6. US 11541045

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  7. US 11291663

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  8. US 11207314

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  9. US 11124839

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  10. US 10980793

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  11. US 10806730

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  12. US 10471055

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

  13. US 10335404

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  14. US 10301317

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  15. US 10292979

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  16. US 10137121

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  17. US 10022364

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  18. US 9956215

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  19. US 9951078

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  20. US 9707221

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  21. US 9624228

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.